Activating and Dominant Inactivating C-Kit Catalytic Domain Mutations in Distinct Clinical Forms of Human Mastocytosis

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.96.4.1609
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Chronic Myelogenous Leukemia With Acquired C-Kit Activating Mutation and Transient Bone Marrow Mastocytosis

The Hematology Journal
2004English

"Occult" Mastocytosis With Activating C-Kit Point Mutation Evolving Into Systemic Mastocytosis Associated With Plasma Cell Myeloma and Secondary Amyloidosis

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Germline Mutations of KIT in Gastrointestinal Stromal Tumor (GIST) and Mastocytosis

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2016English

Mutations of C-Kit JM Domain Are Found in a Minority of Human Gastrointestinal Stromal Tumors

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Advanced Systemic Mastocytosis: The Impact of KIT Mutations in Diagnosis, Treatment, and Progression

European Journal of Haematology
MedicineHematology
2013English

Mastocytosis Cells Bearing the C-Kit Activating Point Mutation Are Characterized by Hypersensitivity to Stem Cell Factor (SCF) and Increased Apoptosis

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Canine and Human Gastrointestinal Stromal Tumors Display Similar Mutations in C-Kit Exon 11

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Activating FLT3 Mutations in CD117/KIT+ T-Cell Acute Lymphoblastic Leukemias

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Actionable Activating Oncogenic ERRB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy